NO961797D0 - Anvendelse av benzopyranderivater for fremstilling av farmasöytiske sammensetninger beregnet for behandling av patologier forbundet med den Na+-uavhengige C1-HCO3-utbytter - Google Patents
Anvendelse av benzopyranderivater for fremstilling av farmasöytiske sammensetninger beregnet for behandling av patologier forbundet med den Na+-uavhengige C1-HCO3-utbytterInfo
- Publication number
- NO961797D0 NO961797D0 NO961797A NO961797A NO961797D0 NO 961797 D0 NO961797 D0 NO 961797D0 NO 961797 A NO961797 A NO 961797A NO 961797 A NO961797 A NO 961797A NO 961797 D0 NO961797 D0 NO 961797D0
- Authority
- NO
- Norway
- Prior art keywords
- hco3
- yields
- independent
- preparation
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9505361A FR2733685B1 (fr) | 1995-05-05 | 1995-05-05 | Utilisation des derives du benzopyrane pour l'obtention de compositions pharmaceutiques destinees au traitement des pathologies liees a l'echangeur c1-/hc03-, na+ independant |
Publications (2)
Publication Number | Publication Date |
---|---|
NO961797D0 true NO961797D0 (no) | 1996-05-03 |
NO961797L NO961797L (no) | 1996-11-06 |
Family
ID=9478712
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO961797A NO961797L (no) | 1995-05-05 | 1996-05-03 | Anvendelse av benzopyranderivater for fremstilling av farmasöytiske sammensetninger beregnet for behandling av patologier forbundet med den Na+-uavhengige C1-HCO3-utbytter |
Country Status (9)
Country | Link |
---|---|
US (1) | US5703118A (no) |
EP (1) | EP0740936A3 (no) |
JP (1) | JPH08301754A (no) |
CN (1) | CN1136920A (no) |
AU (1) | AU5204396A (no) |
CA (1) | CA2175747A1 (no) |
FR (1) | FR2733685B1 (no) |
NO (1) | NO961797L (no) |
ZA (1) | ZA963520B (no) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6008208A (en) * | 1995-10-23 | 1999-12-28 | Osteoscreen, Inc. | Compositions and methods for treating bone deficit conditions |
EP0973513A4 (en) * | 1996-10-23 | 2003-03-19 | Zymogenetics Inc | COMPOSITIONS AND METHODS FOR TREATING CONDITIONS ASSOCIATED WITH BONE DEFICIT |
FR2756284B1 (fr) * | 1996-11-26 | 2000-04-28 | Adir | Nouveaux derives du benzopyrane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
WO2001014316A1 (en) * | 1999-08-24 | 2001-03-01 | Virginia Commonwealth University | Substituted chiral allosteric hemoglobin modifiers |
FI20011507A0 (fi) * | 2001-07-10 | 2001-07-10 | Orion Corp | Uusia yhdisteitä |
EP1517688A2 (de) | 2002-06-19 | 2005-03-30 | Solvay Pharmaceuticals GmbH | Arzneimittel zur behandlung von eine inhibition oder aktivitätsverminderung von ph-wert-regulierenden bikarbonat-transporter-proteinen erfordernden erkrangungen |
FI20030030A0 (fi) * | 2003-01-09 | 2003-01-09 | Orion Corp | Uusia yhdisteitä |
US20070259966A1 (en) * | 2004-04-22 | 2007-11-08 | Allos Therapeutics, Inc. | Coadministration of Radiation, Efaproxiral Sodium, and Supplemental Oxygen for the Treatment of Cancer |
US8349066B2 (en) * | 2006-09-21 | 2013-01-08 | Ppg Industries Ohio, Inc. | Low temperature, moisture curable coating compositions and related methods |
CN101274765B (zh) * | 2007-03-30 | 2011-11-30 | 中国石油化工股份有限公司 | 一种含贵金属的微孔钛硅材料及其制备方法 |
CN104250253B (zh) * | 2014-09-12 | 2017-04-05 | 辽宁大学 | 取代四氢化萘酰胺类化合物及其药学上可接受的盐及制备方法和应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1338012C (en) * | 1987-04-27 | 1996-01-30 | John Michael Mccall | Pharmaceutically active amines |
JPH02215778A (ja) * | 1989-02-14 | 1990-08-28 | Kuraray Co Ltd | 3,4―ジヒドロ―2h―ベンゾピラン誘導体及びその医薬用途 |
US5099012A (en) * | 1990-12-11 | 1992-03-24 | Eastman Kodak Company | Chroman-2-carboxamide conjugates and their use for treatment of reperfusion injury |
JP3053490B2 (ja) * | 1991-02-25 | 2000-06-19 | 杏林製薬株式会社 | チアゾリジン−2,4−ジオン誘導体とその塩及び製造法 |
FR2676056B1 (fr) * | 1991-05-03 | 1993-07-16 | Adir | Nouveaux derives du benzopyranne leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
-
1995
- 1995-05-05 FR FR9505361A patent/FR2733685B1/fr not_active Expired - Fee Related
-
1996
- 1996-05-02 EP EP96400931A patent/EP0740936A3/fr not_active Withdrawn
- 1996-05-02 JP JP8111572A patent/JPH08301754A/ja active Pending
- 1996-05-03 CA CA002175747A patent/CA2175747A1/fr not_active Abandoned
- 1996-05-03 US US08/643,257 patent/US5703118A/en not_active Expired - Fee Related
- 1996-05-03 ZA ZA963520A patent/ZA963520B/xx unknown
- 1996-05-03 AU AU52043/96A patent/AU5204396A/en not_active Abandoned
- 1996-05-03 NO NO961797A patent/NO961797L/no not_active Application Discontinuation
- 1996-05-03 CN CN96104494A patent/CN1136920A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
NO961797L (no) | 1996-11-06 |
EP0740936A2 (fr) | 1996-11-06 |
FR2733685A1 (fr) | 1996-11-08 |
CN1136920A (zh) | 1996-12-04 |
JPH08301754A (ja) | 1996-11-19 |
AU5204396A (en) | 1996-11-14 |
ZA963520B (en) | 1996-11-13 |
CA2175747A1 (fr) | 1996-11-06 |
US5703118A (en) | 1997-12-30 |
EP0740936A3 (fr) | 1997-01-15 |
FR2733685B1 (fr) | 1997-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO914667D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive arylderivater | |
HUP9701694A3 (en) | Indolinone derivatives for the treatment of disease, use thereof, pharmaceutical compositions containing these compounds | |
PT1093815E (pt) | Formulacao oral de 2-metil-tieno-benzodiazepina | |
EE04613B1 (et) | Sahhariidijääkidega asendatud 1,4-bensotiasepiin-1,1-dioksiidi derivaadid, meetod nende valmistamiseks, ühendite kasutamine ning neid sisaldav ravim | |
NO914036L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater | |
NO903088D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive diazepin-derivater. | |
ZA983602B (en) | Use of tetrahydropyridine derivatives for the preparation of drugs for the treatment of diseases which cause demyelination | |
NO953367D0 (no) | Anvendelse av substituerte 4-fenyl-6-amino-nikotinsyre-derivater som legemidler | |
NO961797D0 (no) | Anvendelse av benzopyranderivater for fremstilling av farmasöytiske sammensetninger beregnet for behandling av patologier forbundet med den Na+-uavhengige C1-HCO3-utbytter | |
NO982237L (no) | FremgangsmÕte for fremstilling av fenylimidazolidinderivater | |
MA23663A1 (fr) | Procede de preparation de formulations pharmaceutiques | |
NO914053L (no) | Fremgangsmaate for fremstilling av 8-klorokinolonderivater | |
HUP9901247A3 (en) | Use of naphthimidazole-, naphthoxazole- and naphthothiazole-diones for the preparation of pharmaceutical compositions treating diseases caused by vascular function deficiency | |
EE04095B1 (et) | Ketoliidide ja nende farmatseutiliselt vastuvõetavate soolade kasutamine farmatseutiliste kompositsioonide valmistamiseks | |
IT1277117B1 (it) | Composizioni farmaceutiche per il trattamento delle ipercolesterolemie | |
BR9307182A (pt) | Composições farmacêuticas de 2-oxindol-1-carboxamidas 3-substituídas | |
NO20001895D0 (no) | Anvendelse av glykosaminoglykaner for fremstilling av farmasøytiske preparater for behandling av diabetes assosierte- øyesykdommer | |
NO914985L (no) | Fremgangsmaate for fremstilling av 15-nitro-tabersonin-derivater | |
HUP9801985A3 (en) | Use of cystine derivatives for the preparation of pharmaceutical compositions useful for the treatment of restenosis | |
NO972129D0 (no) | Fremgangsmåte for fremstilling av 1-halo-3-trialkylsilanyl-benzenderivater | |
NO962809D0 (no) | Fremgangsmåte for fremstilling av N-substituerte 4-ketoprolinderivater | |
NO914452D0 (no) | Fremgangsmaate for fremstilling av isokinolinderivater | |
NO943480L (no) | Fremgangsmåte for direktetilpasning av proteser | |
NO964519D0 (no) | Fremgangsmåte for fremstilling av chitosanalkylderivater | |
NO994140D0 (no) | Farmasöytisk sammensetning for den programerte frigivelse av deksfenfluramin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |